Prospects and Challenges for the Commercialization of Biosimilars: Perspectives from the EU, Japan, and the US.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 3, p. 79, doi. 10.5912/jcb751
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2016 AND VI 22 AND IP 3
Results: 5
1
2
Biotechnology, a Strategic Planning Orphan: Towards an Effective Strategy Framework for Biotechnology Firms.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 3, p. 118, doi. 10.5912/jcb748
- By:
- Publication type:
- Article
3
Bioinformatics Patents -- The Challenges.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 3, p. 64, doi. 10.5912/jcb744
- By:
- Publication type:
- Article
4
Industry Partnerships, Key Success Factor to Win in the Biosimilars Space.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 3, p. 114, doi. 10.5912/jcb740
- By:
- Publication type:
- Article
5
Business Model Innovation Opportunities for the Biopharmaceutical Industry: A Systematic Review.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 3, p. 19, doi. 10.5912/jcb735
- By:
- Publication type:
- Article